MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0002692
Edemera Global Private Limited
Edemera Global Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.92 Cr
▲ 400% YoY
Net profit · FY 2025
₹10,111
Net margin 0%
EBITDA · FY 2025
₹6.66 Lakh
EBITDA margin 2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
9
Provident fund records
Directors on board
3
As per MCA filings
About Edemera Global Private Limited
Data last updated:
Edemera Global Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52100TG2020PTC142376. Its GSTIN is 36AAFCE9999L2ZK (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Lakshmi Bhargavi Pappu and Balaraju Edem.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B No 311 Swarnajayanthi Commercial Complex Ameerpet, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.92 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10,111 (net margin 0%) and EBITDA of ₹6.66 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 139% over three years.
The company has about 9 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Edemera Global Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0002692).
Company details
CIN U52100TG2020PTC142376
Registration Number 142376
Incorporation Date 01 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0002692
Recognitions & Rankings of Edemera Global
Contact details
Edemera Global Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressB No 311 Swarnajayanthi Commercial Complex Ameerpet, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Edemera Global Private Limited, buy the company report.
Comprehensive company report
Edemera Global Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Edemera Global is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Edemera Global Private Limited, buy the company report.
Financials of Edemera Global Private Limited
FY 2025 filings availableEdemera Global Private Limited reported revenue of ₹2.92 Cr (up 400% YoY) for FY 2025.
Revenue · FY 2025
₹2.92 Cr ▲ 400%
Net profit · FY 2025
₹10,111 margin 0%
EBITDA · FY 2025
₹6.66 Lakh margin 2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 400%
3 years · compounded
▲ 139%
EBITDA CAGR growth
1 year
▲ 125%
3 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 139% over three years, including 400% growth in the latest year. EBITDA rose 125% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,111 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Edemera Global Private Limited, buy the company report.
Board of directors of Edemera Global Private Limited
Edemera Global has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmi Bhargavi Pappu | Director | 01 Aug 2020 | 6 Years 2 Months | Current |
| Balaraju Edem | Director | 01 Aug 2020 | 6 Years 2 Months | Current |
| Sajendra Reddy Linga Also directs: Yashod Private Limited | Director | 01 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Edemera Global Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Teora Lifesciences Private Limited | ₹3.01 Cr (FY 2025) | 1404.0% | Bangalore, Karnataka, India | |||
| Edemera Global Private Limitedthis company | ₹2.92 Cr (FY 2025) | ₹10,111 | 0% | 400.0% | Hyderabad, Telangana, India | |
| BRF Lifescience Private Limited | ₹2.85 Cr (FY 2024) | 6.0% | Chennai, Tamil Nadu, India | |||
| Propharmex India Private Limited | ₹2.84 Cr (FY 2025) | -8.0% | Nacharam, Telangana, India |
To see the full peer comparison of Edemera Global Private Limited, buy the company report.
Legal cases
Edemera Global Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Total cases
3
Filed against the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
Cases on record (1 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by Timetech Lifesciences Ltd, Rep.By Nagaraju Gouth | Pending |
To see the full case history of Edemera Global Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edemera Global Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Edemera Global has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE9999L2ZK | Telangana | Active | 15 Jul 2021 |
To see the full GST registrations and return filing status of Edemera Global Private Limited, buy the company report.
Recent activity
Edemera Global Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Balaraju Edem was appointed as Director on 01 Aug 2020.
AGM
Edemera Global Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Edemera Global Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Balaraju Edem was appointed as Director.
Appointed
Lakshmi Bhargavi Pappu was appointed as Director.
Appointed
Sajendra Reddy Linga was appointed as Director.
Incorporation
01 Aug 2020
Edemera Global Private Limited was registered on 01 Aug 2020 with Roc Hyderabad & aged 6 years 2 months as per MCA records.
Frequently asked questions
Edemera Global is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 August 2020 (6+ years old) and is registered under CIN U52100TG2020PTC142376.
Edemera Global has 3 current directors:
- Lakshmi Bhargavi Pappu - Director
- Balaraju Edem - Director
- Sajendra Reddy Linga - Director
The latest financial statements of Edemera Global on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Edemera Global is 36AAFCE9999L2ZK, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Edemera Global is U52100TG2020PTC142376. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edemera Global has 3 court cases on record: 3 filed against it. 3 are pending.
Edemera Global was incorporated on 01 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Edemera Global by revenue are Teora Lifesciences Private Limited, BRF Lifescience Private Limited, Propharmex India Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Balaraju Edem was appointed as Director on 01 Aug 2020. Lakshmi Bhargavi Pappu was appointed as Director on 01 Aug 2020. Sajendra Reddy Linga was appointed as Director on 01 Aug 2020.
Yes, Edemera Global is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0002692).
The registered office of Edemera Global is at B No 311 Swarnajayanthi Commercial Complex Ameerpet, Hyderabad, Telangana, India – 500038.